Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
3,158,681
-
Share change
-
+3,154,885
-
Total reported value
-
$18,681,000
-
Price per share
-
$5.92
-
Number of holders
-
7
-
Value change
-
+$18,658,000
-
Number of buys
-
6
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2014
As of 31 Dec 2014,
Aptose Biosciences Inc. - Common Shares was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,158,681 shares.
The largest 7 holders included
FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, BAKER BROS. ADVISORS LP, BVF INC/IL, Tower Research Capital LLC (TRC), ROYAL BANK OF CANADA, and UBS Group AG.
This page lists
7
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.